MétaCan
Menu
Retour à la cohorte
Enregistrement W4239210079 · doi:10.1093/humrep/deab043

Corrigendum. ICSI does not improve reproductive outcomes in autologous ovarian response cycles with non-male factor subfertility

2021· erratum· en· W4239210079 sur OpenAlexaff
P R Supramanian, Ingrid Granne, E. Ohuma, Lee Nai Lim, Enda McVeigh, Radha Venkatakrishnan, Christian M. Becker, Monica Mittal

Notice bibliographique

RevueHuman Reproduction · 2021
Typeerratum
Langueen
DomaineMedicine
ThématiqueReproductive Biology and Fertility
Établissements canadiensSickKids FoundationHospital for Sick Children
Organismes subventionnairesnon disponible
Mots-clésGynecologyMedicineAndrology

Résumé

récupéré en direct d'OpenAlex

Hum Reprod 2020:35: pp. 583–594 The authors would like to apologise for the errors in Table 1, Table 3 and the manuscript of the above article. The errors, unfortunately, occurred in the process of transcribing the data across three platforms (Microsoft Excel, SPPS and then on to Microsoft Word). This has now been rechecked by three different individuals to avoid further transcription errors. Amendments have also been made to Table 4 to further clarify its intention. Distribution of IVF and ICSI cycles in poor ovarian response according to female age groups, number of previous ART cycles, number of previous live birth(s) through ART, oocyte yield, stage of transfer, number of embryos transferred and a sub-analysis of all ovarian response categories. 1466 31742 18556 (55%) 1357 591 (2%) 0.107 0.504 62641 33436 (12%) 29205 (10%) 15892 8067 (33%) 7825 (34%) 1466 31742 18556 (55%) 1357 591 (2%) 0.107 0.504 62641 33436 (12%) 29205 (10%) 15892 8067 (33%) 7825 (34%) Multivariable logistic regression–adjusted for female age, number of previous ART cycles, number of previous live births through ART, oocyte yield. The data is expressed as whole numbers and percentages. The adjusted Odds Ratio (aOR) is displayed as the odds of performing ICSI over IVF for each of the variables. Distribution of IVF and ICSI cycles in poor ovarian response according to female age groups, number of previous ART cycles, number of previous live birth(s) through ART, oocyte yield, stage of transfer, number of embryos transferred and a sub-analysis of all ovarian response categories. 1466 31742 18556 (55%) 1357 591 (2%) 0.107 0.504 62641 33436 (12%) 29205 (10%) 15892 8067 (33%) 7825 (34%) 1466 31742 18556 (55%) 1357 591 (2%) 0.107 0.504 62641 33436 (12%) 29205 (10%) 15892 8067 (33%) 7825 (34%) Multivariable logistic regression–adjusted for female age, number of previous ART cycles, number of previous live births through ART, oocyte yield. The data is expressed as whole numbers and percentages. The adjusted Odds Ratio (aOR) is displayed as the odds of performing ICSI over IVF for each of the variables. Clinical pregnancy, live birth, singleton and multiple birth rate per treatment cycle in all ovarian response for IVF and ICSI cycles distributed by the variables female age, number of previous ART cycles, number of previous live births through ART, oocyte yield and stage of embryo transfer expressed in whole numbers and as a percentage. 17352 (9.4) 57704 (39.9) 50692 (35.1) 34905 (24.2) 15787 (10.9) 4947 (14.8) 17352 (9.4) 57704 (39.9) 50692 (35.1) 34905 (24.2) 15787 (10.9) 4947 (14.8) Clinical pregnancy, live birth, singleton and multiple birth rate per treatment cycle in all ovarian response for IVF and ICSI cycles distributed by the variables female age, number of previous ART cycles, number of previous live births through ART, oocyte yield and stage of embryo transfer expressed in whole numbers and as a percentage. 17352 (9.4) 57704 (39.9) 50692 (35.1) 34905 (24.2) 15787 (10.9) 4947 (14.8) 17352 (9.4) 57704 (39.9) 50692 (35.1) 34905 (24.2) 15787 (10.9) 4947 (14.8) The odds ratio of IVF vs ICSI for clinical pregnancy and live birth outcome subcategorised by 5-year intervals from 2002 up to 2016 for poor ovarian response cohort and by oocyte yield for 1998 to 2016, with 99.5% and 95% confidence intervals and p-values respectively. IVF (n=11,651) ICSI (n=11,362) 1.04 (0.93 – 1.16) 1 0.354 1.03 (0.91 – 1.16) 1 0.500 IVF (n=10,743) ICSI (n=9,836) 1.13 (0.99 – 1.28) 1 0.010 1.14 (0.99 – 1.30) 1 0.006 IVF (n=7,293) ICSI (n=5,837) 1.04 (0.89 – 1.22) 1 0.473 1.04 (0.87 – 1.23) 1 0.573 IVF (n=33,436) ICSI (n=29,205) 1.04 (0.97 – 1.12) 1 0.102 1.03 (0.96 – 1.11) 1 0.261 IVF (n=115,639) ICSI (n=123,497) 1.02 (0.99 – 1.05) 1 0.014 1.03 (0.99 – 1.05) 1 0.012 IVF (n=78,504) ICSI (n=91,284) 0.99 (0.96 – 1.02) 1 0.314 0.99 (0.96 – 1.02) 1 0.261 IVF (n=27,829) ICSI (n=33,452) 0.97 (0.92 – 1.02) 1 0.048 0.98 (0.93 – 1.03) 1 0.286 IVF (n=10,750) ICSI (n=12,736) 0.97 (0.90 – 1.06) 1 0.368 0.98 (0.90 – 1.07) 1 0.480 IVF (n=6,275) ICSI (n=6,998) 0.88 (0.77 – 1.00) 1 0.005 0.88 (0.77 – 1.01) 1 0.011 *aOR (95% CI) Clinical Pregnancy *aOR (95% CI) Live Birth IVF (n=18,556) ICSI (n=13,186) 1.05 (0.96 – 1.16) 1 0.126 1.03 (0.93 – 1.14) 1 0.451 IVF (n=66,863) ICSI (n=58,320) 1.04 (1.00 – 1.07) 1 0.005 1.04 (1.00 – 1.08) 1 0.005 IVF (n=47,008) ICSI (n=44,926) 0.99 (0.96 – 1.03) 1 0.671 1.00 (0.96 – 1.04) 1 0.968 IVF (n=17,386) ICSI (n=17,252) 0.97 (0.91 – 1.04) 1 0.187 1.00 (0.93 – 1.07) 1 0.997 IVF (n=6,967) ICSI (n=6,882) 1.02 (0.92 – 1.14) 1 0.530 1.02 (0.92 – 1.14) 1 0.548 IVF (n=4,270) ICSI (n=4,084) 0.91 (0.77 – 1.07) 1 0.109 0.92 (0.78 – 1.09) 1 0.156 IVF (n=11,651) ICSI (n=11,362) 1.04 (0.93 – 1.16) 1 0.354 1.03 (0.91 – 1.16) 1 0.500 IVF (n=10,743) ICSI (n=9,836) 1.13 (0.99 – 1.28) 1 0.010 1.14 (0.99 – 1.30) 1 0.006 IVF (n=7,293) ICSI (n=5,837) 1.04 (0.89 – 1.22) 1 0.473 1.04 (0.87 – 1.23) 1 0.573 IVF (n=33,436) ICSI (n=29,205) 1.04 (0.97 – 1.12) 1 0.102 1.03 (0.96 – 1.11) 1 0.261 IVF (n=115,639) ICSI (n=123,497) 1.02 (0.99 – 1.05) 1 0.014 1.03 (0.99 – 1.05) 1 0.012 IVF (n=78,504) ICSI (n=91,284) 0.99 (0.96 – 1.02) 1 0.314 0.99 (0.96 – 1.02) 1 0.261 IVF (n=27,829) ICSI (n=33,452) 0.97 (0.92 – 1.02) 1 0.048 0.98 (0.93 – 1.03) 1 0.286 IVF (n=10,750) ICSI (n=12,736) 0.97 (0.90 – 1.06) 1 0.368 0.98 (0.90 – 1.07) 1 0.480 IVF (n=6,275) ICSI (n=6,998) 0.88 (0.77 – 1.00) 1 0.005 0.88 (0.77 – 1.01) 1 0.011 *aOR (95% CI) Clinical Pregnancy *aOR (95% CI) Live Birth IVF (n=18,556) ICSI (n=13,186) 1.05 (0.96 – 1.16) 1 0.126 1.03 (0.93 – 1.14) 1 0.451 IVF (n=66,863) ICSI (n=58,320) 1.04 (1.00 – 1.07) 1 0.005 1.04 (1.00 – 1.08) 1 0.005 IVF (n=47,008) ICSI (n=44,926) 0.99 (0.96 – 1.03) 1 0.671 1.00 (0.96 – 1.04) 1 0.968 IVF (n=17,386) ICSI (n=17,252) 0.97 (0.91 – 1.04) 1 0.187 1.00 (0.93 – 1.07) 1 0.997 IVF (n=6,967) ICSI (n=6,882) 1.02 (0.92 – 1.14) 1 0.530 1.02 (0.92 – 1.14) 1 0.548 IVF (n=4,270) ICSI (n=4,084) 0.91 (0.77 – 1.07) 1 0.109 0.92 (0.78 – 1.09) 1 0.156 Clinical pregnancy and live birth outcome adjusted for female age, number of previous ART cycles, number of previous live birth(s) through ART, oocyte yield, stage of transfer, method of fertilisation and number of embryos transferred. Clinical pregnancy and live birth outcome adjusted for female age, oocyte yield, stage of transfer, method of fertilisation and number of embryos transferred. The odds ratio of IVF vs ICSI for clinical pregnancy and live birth outcome subcategorised by 5-year intervals from 2002 up to 2016 for poor ovarian response cohort and by oocyte yield for 1998 to 2016, with 99.5% and 95% confidence intervals and p-values respectively. IVF (n=11,651) ICSI (n=11,362) 1.04 (0.93 – 1.16) 1 0.354 1.03 (0.91 – 1.16) 1 0.500 IVF (n=10,743) ICSI (n=9,836) 1.13 (0.99 – 1.28) 1 0.010 1.14 (0.99 – 1.30) 1 0.006 IVF (n=7,293) ICSI (n=5,837) 1.04 (0.89 – 1.22) 1 0.473 1.04 (0.87 – 1.23) 1 0.573 IVF (n=33,436) ICSI (n=29,205) 1.04 (0.97 – 1.12) 1 0.102 1.03 (0.96 – 1.11) 1 0.261 IVF (n=115,639) ICSI (n=123,497) 1.02 (0.99 – 1.05) 1 0.014 1.03 (0.99 – 1.05) 1 0.012 IVF (n=78,504) ICSI (n=91,284) 0.99 (0.96 – 1.02) 1 0.314 0.99 (0.96 – 1.02) 1 0.261 IVF (n=27,829) ICSI (n=33,452) 0.97 (0.92 – 1.02) 1 0.048 0.98 (0.93 – 1.03) 1 0.286 IVF (n=10,750) ICSI (n=12,736) 0.97 (0.90 – 1.06) 1 0.368 0.98 (0.90 – 1.07) 1 0.480 IVF (n=6,275) ICSI (n=6,998) 0.88 (0.77 – 1.00) 1 0.005 0.88 (0.77 – 1.01) 1 0.011 *aOR (95% CI) Clinical Pregnancy *aOR (95% CI) Live Birth IVF (n=18,556) ICSI (n=13,186) 1.05 (0.96 – 1.16) 1 0.126 1.03 (0.93 – 1.14) 1 0.451 IVF (n=66,863) ICSI (n=58,320) 1.04 (1.00 – 1.07) 1 0.005 1.04 (1.00 – 1.08) 1 0.005 IVF (n=47,008) ICSI (n=44,926) 0.99 (0.96 – 1.03) 1 0.671 1.00 (0.96 – 1.04) 1 0.968 IVF (n=17,386) ICSI (n=17,252) 0.97 (0.91 – 1.04) 1 0.187 1.00 (0.93 – 1.07) 1 0.997 IVF (n=6,967) ICSI (n=6,882) 1.02 (0.92 – 1.14) 1 0.530 1.02 (0.92 – 1.14) 1 0.548 IVF (n=4,270) ICSI (n=4,084) 0.91 (0.77 – 1.07) 1 0.109 0.92 (0.78 – 1.09) 1 0.156 IVF (n=11,651) ICSI (n=11,362) 1.04 (0.93 – 1.16) 1 0.354 1.03 (0.91 – 1.16) 1 0.500 IVF (n=10,743) ICSI (n=9,836) 1.13 (0.99 – 1.28) 1 0.010 1.14 (0.99 – 1.30) 1 0.006 IVF (n=7,293) ICSI (n=5,837) 1.04 (0.89 – 1.22) 1 0.473 1.04 (0.87 – 1.23) 1 0.573 IVF (n=33,436) ICSI (n=29,205) 1.04 (0.97 – 1.12) 1 0.102 1.03 (0.96 – 1.11) 1 0.261 IVF (n=115,639) ICSI (n=123,497) 1.02 (0.99 – 1.05) 1 0.014 1.03 (0.99 – 1.05) 1 0.012 IVF (n=78,504) ICSI (n=91,284) 0.99 (0.96 – 1.02) 1 0.314 0.99 (0.96 – 1.02) 1 0.261 IVF (n=27,829) ICSI (n=33,452) 0.97 (0.92 – 1.02) 1 0.048 0.98 (0.93 – 1.03) 1 0.286 IVF (n=10,750) ICSI (n=12,736) 0.97 (0.90 – 1.06) 1 0.368 0.98 (0.90 – 1.07) 1 0.480 IVF (n=6,275) ICSI (n=6,998) 0.88 (0.77 – 1.00) 1 0.005 0.88 (0.77 – 1.01) 1 0.011 *aOR (95% CI) Clinical Pregnancy *aOR (95% CI) Live Birth IVF (n=18,556) ICSI (n=13,186) 1.05 (0.96 – 1.16) 1 0.126 1.03 (0.93 – 1.14) 1 0.451 IVF (n=66,863) ICSI (n=58,320) 1.04 (1.00 – 1.07) 1 0.005 1.04 (1.00 – 1.08) 1 0.005 IVF (n=47,008) ICSI (n=44,926) 0.99 (0.96 – 1.03) 1 0.671 1.00 (0.96 – 1.04) 1 0.968 IVF (n=17,386) ICSI (n=17,252) 0.97 (0.91 – 1.04) 1 0.187 1.00 (0.93 – 1.07) 1 0.997 IVF (n=6,967) ICSI (n=6,882) 1.02 (0.92 – 1.14) 1 0.530 1.02 (0.92 – 1.14) 1 0.548 IVF (n=4,270) ICSI (n=4,084) 0.91 (0.77 – 1.07) 1 0.109 0.92 (0.78 – 1.09) 1 0.156 Clinical pregnancy and live birth outcome adjusted for female age, number of previous ART cycles, number of previous live birth(s) through ART, oocyte yield, stage of transfer, method of fertilisation and number of embryos transferred. Clinical pregnancy and live birth outcome adjusted for female age, oocyte yield, stage of transfer, method of fertilisation and number of embryos transferred. We would like to emphasise that the transcription errors had no impact on the message of the publication and its academic value. Whilst the ‘n’ numbers were affected, the odds ratio and confidence interval calculations were not, thus preserving the overall scientific impact of the findings from the study.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,003
score de la tête « metaresearch » (Gemma)0,046
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Autre · Signal consensuel: aucune
Score de désaccord entre enseignants0,059
Score d'incertitude au seuil0,199

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0030,046
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0020,001
Études des sciences et des technologies0,0020,002
Communication savante0,0020,001
Science ouverte0,0020,001
Intégrité de la recherche0,0040,005
Charge utile insuffisante (le modèle a refusé de juger)0,0590,037

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,033
Tête enseignante GPT0,304
Écart entre enseignants0,270 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreAutre

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2021
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueHuman ReproductionMême sujetReproductive Biology and FertilityTravaux en français237 207